ASSESSMENT OF THE STATE OF THE COAGULATION LINK OF HEMOSTASIS IN WOMEN WHO TERMINATED NON-DEVELOPING EARLY PREGNANCY WITH MEDICATION

M.Fazilova; S.Sultanov

doi:10.5281/zenodo.7257585

ASSESSMENT OF THE STATE OF THE COAGULATION LINK OF HEMOSTASIS IN WOMEN WHO TERMINATED NON-DEVELOPING EARLY PREGNANCY WITH MEDICATION

27.10.2022 International Scientific Journal "Science and Innovation". Series D. Volume 1 Issue 7

M.Fazilova, S.Sultanov

Abstract. 52 women were examined on the background of medical interruption of non-developing pregnancy for up to 63 days of amenorrhea. Signs of activation of indicators of the coagulation link of hemostasis were revealed - an increase in blood clotting activity against the background of an undeveloped pregnancy and after taking mifepristone, followed by a gradual normalization of hemostatic changes and a decrease in overall blood clotting after taking misoprostol.

Keywords: non-developing pregnancy, mifepristone, misoprostol, medical termination of pregnancy, coagulation link of hemostasis.

References:

1. Amanova A. M. Medical methods for terminating missed pregnancy in the first trimester // Bulletin of KSMA them. I. K. Akhunbaeva. 2016. No. 1. S. 36-39. 2. Grigoryeva N. V. The state of the coagulation link of hemostasis in non-developing early pregnancy depending on the duration of the delay of the dead fetal egg in the uterine cavity / Grigorieva N. V., Bagirov R. N. // Proceedings of the III All-Russian Conference of Young Scientists "Science and innovations of the 21st century”. Surgut: ITs SurGU, 2016. Vol. II. 258 c. pp. 121-124. 3. Karpova I. A., Polyakova V. A., Grigoryeva N. V., Aksent’eva A. V., Bagirov R. N. Peculiarities of changes in the coagulation link of hemostasis against the background of medical interruption of a non-developing early pregnancy , V. A. Platitsin, E. V. Zolotukhina, N. N. Buslaeva // University Medicine of the Urals. 2016. No. 4. S. 5-7. 4. Karpova I. A. Pathogenetic rationale for the correction of hemostatic changes against the background of contraceptive hormonal systems / I. A. Karpova, V. A. Polyakova, A. M. Chernova, V. A. Platitsin, R. N. Bagirov // Academic Journal of Western Siberia. 2016. Vol. 12, No. 1. 5. Nemanova S. B. The effect of a complex effect on the hemostasis system of drugs (antigestagens and prostaglandins) used to terminate pregnancy in a short period / S. B. Nemanova et al. // Journal of Obstetrics and Women's Diseases. 2011. T. LX, No. 1. S. 47-55. 6. Polyakova V. A. The results of the effectiveness of medical termination of pregnancy using one tablet of mifepristone / V. A. Polyakova, O. Kh. Kuzakberdieva, I. A. Karpova, T. P. Shevlyukova // University science: a look into the future " Proceedings of the International Scientific and Practical Conference Dedicated to the 81st Anniversary of the Kursk State Medical University and the 50th Anniversary of the Pharmaceutical University. In 3 volumes. Edited by V. A. Lazarenko, P. V. Tkachenko, P. V. Kalutsky, O. O. Kurilova. 2016. S. 40-42. 7. Bettahar K., Boisrame T., Cavillon V. et all. Medical induced abortion // J Gynecol Obstet Biol Reprod (Paris). 2016. 8. Зокирова Н. и др. Оптимизация ведение женщен с пузырным заносом //Журнал вестник врача. – 2014. – Т. 1. – №. 01. – С. 89-93. 9. Каримова M., Асатулаев, А., & Тугизова, Д. (2022). Оценка эффективности различных методов лечения больных с местнораспространненным раком молочной железы. Журнал вестник врача, 1(04), 69–70. извлечено от https://inlibrary.uz/index.php/doctors_herald 10. Тугизова Д. И., Джураев М. Д., Каримова М. Н. ФАКТОРЫ ПРОГНОЗА ПРИ РАКЕ ШЕЙКИ МАТКИ, АССОЦИИРОВАННЫЕ С БЕРЕМЕННОСТЬЮ. 11. Тугизова Д. И., Каримова М. Н., Рахимов Н. М. ТАКТИКА ВЕДЕНИЯ БЕРЕМЕННЫХ С ИНВАЗИВНЫМ РАКОМ ШЕЙКИ МАТКИ (ЛИТЕРАТУРНЫЙ ОБЗОР) //ЖУРНАЛ БИОМЕДИЦИНЫ И ПРАКТИКИ. – 2022. – Т. 7. – №. 3.